• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Sanofi-Aventis ADR

Sanofi-Aventis ADR

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Rentrak Announces Official Worldwide Box Office Results for Weekend of December 7, 2014

    Rentrak Announces Official Worldwide Box Office Results for Weekend of December 7, 2014

  2. Sanofi Receives FDA Approval of Priftin® (rifapentine) Tablets for the Treatment of Latent Tuberculosis Infection

    Sanofi Receives FDA Approval of Priftin® (rifapentine) Tablets for the Treatment of Latent Tuberculosis Infection

  3. UPDATE: Cypress, Spansion shares rally on merger plan

    UPDATE: Cypress, Spansion shares rally on merger plan

  4. Rentrak Announces Official Worldwide Box Office Results for Weekend of November 30, 2014

    Rentrak Announces Official Worldwide Box Office Results for Weekend of November 30, 2014

  5. Sanofi Shakes Off Patent Losses

    The drugmaker faces less long-term volatility as the focus shifts to steady businesses.

  6. Rentrak Announces Official Worldwide Box Office Results for Weekend of November 23, 2014

    Rentrak Announces Official Worldwide Box Office Results for Weekend of November 23, 2014

  7. ADR Shares End Mixed; Sanofi Shares Trade Actively

    ADR Shares End Mixed; Sanofi Shares Trade Actively

  8. Regeneron and Sanofi Announce that Dupilumab Has Received FDA Breakthrough Therapy Designation in Atopic Dermatitis

    Regeneron and Sanofi Announce that Dupilumab Has Received FDA Breakthrough Therapy Designation in Atopic Dermatitis

  9. Regeneron and Sanofi Announce New Results from Six Phase 3 Trials Showing that Alirocumab Significantly Reduced LDL Cholesterol

    Regeneron and Sanofi Announce New Results from Six Phase 3 Trials Showing that Alirocumab Significantly Reduced LDL Cholesterol

  10. Genzyme and Isis Present KYNAMRO® Clinical Data at the American Heart Association

    Genzyme and Isis Present KYNAMRO® Clinical Data at the American Heart Association

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.